89 related articles for article (PubMed ID: 8367372)
1. [Estimation of selected markers of bone metabolism inpatients with nephrolithiasis].
Kuczera M; Wiecek A; Kokot F
Pol Arch Med Wewn; 1993 May; 89(5):385-93. PubMed ID: 8367372
[TBL] [Abstract][Full Text] [Related]
2. Markers of bone turnover in patients with nephrolithiasis.
Kuczera M; Wiecek A; Kokot F
Int Urol Nephrol; 1997; 29(5):523-8. PubMed ID: 9413756
[TBL] [Abstract][Full Text] [Related]
3. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
4. [Behavior of sex hormone and gonadotropin secretion in men with active nephrolithiasis].
Kuczera M; Kiersztejn M; Kokot F; Klin M
Endokrynol Pol; 1993; 44(4):539-47. PubMed ID: 8055822
[TBL] [Abstract][Full Text] [Related]
5. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
Lindsjö M
Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
[TBL] [Abstract][Full Text] [Related]
6. Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis.
Baggio B; Budakovic A; Nassuato MA; Vezzoli G; Manzato E; Luisetto G; Zaninotto M
Kidney Int; 2000 Sep; 58(3):1278-84. PubMed ID: 10972691
[TBL] [Abstract][Full Text] [Related]
7. Frequency of renal phosphate leak among patients with calcium nephrolithiasis.
Prié D; Ravery V; Boccon-Gibod L; Friedlander G
Kidney Int; 2001 Jul; 60(1):272-6. PubMed ID: 11422761
[TBL] [Abstract][Full Text] [Related]
8. [Determination of calcium, oxalate and inhibitory activity of the urine in patients with calcium nephrolithiasis].
Han KH; Cao LC; Ying YL
Zhonghua Wai Ke Za Zhi; 1986 Mar; 24(3):173-5, 190. PubMed ID: 3757655
[No Abstract] [Full Text] [Related]
9. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
[TBL] [Abstract][Full Text] [Related]
10. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
Müller G; Schütte W; Berg W; Möller T
Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
[TBL] [Abstract][Full Text] [Related]
11. [Markers of calcium--phosphate metabolism and bones alterations in long term kidney transplant patients].
Spiechowicz U; Kokot F; Wiecek A
Przegl Lek; 2003; 60(11):690-4. PubMed ID: 15058034
[TBL] [Abstract][Full Text] [Related]
12. Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis.
Arrabal-Polo MA; Arrabal-Martin M; de Haro-Muñoz T; Poyatos-Andujar A; Palæo-Yago F; Zuluaga-Gomez A
Urology; 2012 Jan; 79(1):48-54. PubMed ID: 21908029
[TBL] [Abstract][Full Text] [Related]
13. Renal excretion of oxalate in patients with chronic renal failure or nephrolithiasis.
Chen SM; Chen TW; Lee YH; Chu WY; Young TK
J Formos Med Assoc; 1990 Aug; 89(8):651-6. PubMed ID: 1981225
[TBL] [Abstract][Full Text] [Related]
14. A 7-week reduction in salt intake does not contribute to markers of bone metabolism in young healthy subjects.
Natri AM; Kärkkäinen MU; Ruusunen M; Puolanne E; Lamberg-Allardt C
Eur J Clin Nutr; 2005 Mar; 59(3):311-7. PubMed ID: 15674316
[TBL] [Abstract][Full Text] [Related]
15. [Selected indicators of calcium-phosphate metabolism in patients with diabetes mellitus].
Błasiak M; Kuska J; Kokot F; Irzyniec T
Endokrynol Pol; 1989; 40(5):251-62. PubMed ID: 2641514
[TBL] [Abstract][Full Text] [Related]
16. An acute intake of phosphate increases parathyroid hormone secretion and inhibits bone formation in young women.
Kärkkäinen M; Lamberg-Allardt C
J Bone Miner Res; 1996 Dec; 11(12):1905-12. PubMed ID: 8970892
[TBL] [Abstract][Full Text] [Related]
17. Urinary oxalate and calcium excretion by dogs and cats diagnosed with calcium oxalate urolithiasis.
Dijcker JC; Kummeling A; Hagen-Plantinga EA; Hendriks WH
Vet Rec; 2012 Dec 22-29; 171(25):646. PubMed ID: 23180150
[No Abstract] [Full Text] [Related]
18. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
Pak CY; Oata M; Lawrence EC; Snyder W
J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
[TBL] [Abstract][Full Text] [Related]
19. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
[TBL] [Abstract][Full Text] [Related]
20. [Hypercalciuria and primary hyperparathyroidism in patients with kidney calculi. I. Hypercalciuria].
Nieszporek T; Kokot F; Skrzypek J; Wieczorek M; Kuska J
Pol Arch Med Wewn; 1992 Jan; 87(1):41-8. PubMed ID: 1641363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
